Vivek S. Kavadi, M.D., MBA, FASTRO

Provider Type: Physician

Specialties:

Radiation Oncology

Board Certifications:

Radiation Oncology

Texas Oncology-Sugar Land
1350 First Colony Blvd.
Sugar Land, TX 77479
T: 281-277-5200
contact_phone Download Contact Card

Metro Area: Houston

Spoken Language: English

Downloads

Biography

General Summary

Dr. Kavadi has been practicing radiation oncology for over 25 years. His areas of interest are in breast cancer and prostate cancer. He has led network radiation oncology efforts in clinical, research, and operational areas during his tenure. He currently serves as the Chief Radiation Oncology Officer for the US Oncology Network and McKesson which has more than 230 radiation oncologists nationwide. In this capacity he will be working to advance the radiation oncology programs throughout the network and enhance integrated oncology care overall.

To learn more about our Breast Cancer Nurse Navigator program, visit https://www.texasoncology.com/houstonbreastcancer

Education

Residency in Radiation Oncology
Chief Resident The University of Texas MD Anderson Cancer Center, Houston, TX
Medical Doctorate
Harvard Medical School, Boston, MA
Master of Business Administration
The Wharton School, University of Pennsylvania, Philadelphia, PA
Bachelor of Science in Biochemistry
Rice University, Houston, TX

Accolades & Memberships

Executive Committee, Texas Oncology
Medical Director, Radiation Oncology, The US Oncology Network
Chairman, Radiation Executive Committee, The US Oncology Network
Primary Investigator for US Oncology RTOG Affiliation
Executive Committee, National Policy Board, The US Oncology Network
American Society for Therapeutic Radiology and Oncology (ASTRO)
Health Policy Council, ASTRO
Government Relations Committee, ASTRO
Gilbert H. Fletcher Society
Board Member, Association for Community Broadcasting
Summa Cum Laude, Rice University
Phi Beta Kappa, Rice University
Chief Resident, The University of Texas MD Anderson Cancer Center

Publications

Modeling the Impact of Cardiopulmonary Irradiation on Overall Survival in NRG Oncology Trial RTOG 0617
Clinical Cancer Research: An Official Journal of the American Association for Cancer Research, 2020
Patterns of Failure Observed in the 2-Step Institution Credentialing Process for NRG Oncology/Radiation Therapy Oncology Group 1005 (NCT01349322) and Lessons Learned
Practical Radiation Oncology, 2020
Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non-Small-Cell Lung Cancer
Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 2020
Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non-Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial
Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 2017

Latest News

Show all News

Research Interest

Dr. Kavadi has a clinical interest in prostate and breast cancer.

Other Information

Dr. Kavadi is married with three children. He is an avid sports fan and enjoys playing golf, tennis and volleybal.